Intravenous Tissue Plasminogen Activator as Provocateur of Myocardial Infarction

Am J Ther. 2017 Jul/Aug;24(4):e489-e490. doi: 10.1097/MJT.0000000000000494.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Intravenous
  • Aged
  • Cardiac Catheterization / adverse effects
  • Electrocardiography
  • Fatal Outcome
  • Humans
  • Male
  • Myocardial Infarction / chemically induced*
  • Myocardial Infarction / diagnosis
  • Stroke / diagnostic imaging
  • Stroke / drug therapy*
  • Stroke / etiology
  • Syncope / therapy
  • Thrombolytic Therapy / adverse effects*
  • Thrombolytic Therapy / methods
  • Tissue Plasminogen Activator / administration & dosage
  • Tissue Plasminogen Activator / adverse effects*
  • Tomography, X-Ray Computed

Substances

  • Tissue Plasminogen Activator